These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26670093)

  • 1. Actual costs of cancer drugs in 15 European countries.
    van Harten WH; Wind A; de Paoli P; Saghatchian M; Oberst S
    Lancet Oncol; 2016 Jan; 17(1):18-20. PubMed ID: 26670093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cost/benefit analysis of cancer drugs].
    Jordan B
    Med Sci (Paris); 2020 Nov; 36(11):1095-1097. PubMed ID: 33151876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pricing increases for cancer drugs sparks investigation.
    Venkatesan P
    Lancet Oncol; 2017 Jul; 18(7):e372. PubMed ID: 28552213
    [No Abstract]   [Full Text] [Related]  

  • 4. Price, value, and the cost of cancer drugs.
    Fojo T; Lo AW
    Lancet Oncol; 2016 Jan; 17(1):3-5. PubMed ID: 26758749
    [No Abstract]   [Full Text] [Related]  

  • 5. Lowering the High Cost of Cancer Drugs--II.
    Messori A; Fadda V; Trippoli S
    Mayo Clin Proc; 2016 Mar; 91(3):397-9. PubMed ID: 26944244
    [No Abstract]   [Full Text] [Related]  

  • 6. Not all discounts on certain cancer drugs have disappeared.
    Thompson CA
    Am J Health Syst Pharm; 2015 Feb; 72(4):259-60. PubMed ID: 25631827
    [No Abstract]   [Full Text] [Related]  

  • 7. Market uptake of biologic and small-molecule--targeted oncology drugs in Europe.
    Obradovic M; Mrhar A; Kos M
    Clin Ther; 2009 Dec; 31(12):2940-52. PubMed ID: 20110034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment.
    Lane JD; Friedberg MW; Bennett CL
    JAMA Oncol; 2016 Feb; 2(2):274-6. PubMed ID: 26658959
    [No Abstract]   [Full Text] [Related]  

  • 9. Market spiral pricing of cancer drugs.
    Light DW; Kantarjian H
    Cancer; 2013 Nov; 119(22):3900-2. PubMed ID: 24002792
    [No Abstract]   [Full Text] [Related]  

  • 10. Having "Skin in the Game" and Allowing Cross-Border Importation of Drugs to Lower High Prices of Cancer Drugs.
    Kantarjian H; Mathisen MS; Lipton JH
    JAMA Oncol; 2015 Sep; 1(6):729-30. PubMed ID: 26182331
    [No Abstract]   [Full Text] [Related]  

  • 11. Why are cancer drugs so expensive in the United States, and what are the solutions?
    Kantarjian H; Rajkumar SV
    Mayo Clin Proc; 2015 Apr; 90(4):500-4. PubMed ID: 25792242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of Cancer Drugs: Something Has To Give.
    Bender E
    Manag Care; 2018 May; 27(5):18-22. PubMed ID: 29763403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing profits with public good.
    Laking G
    Nurs N Z; 2015 May; 21(4):15. PubMed ID: 26062361
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical funding decisions must balance therapeutic innovation, opportunity costs and patient equity.
    Ragupathy R; Jameson M
    N Z Med J; 2016 Aug; 129(1440):22-4. PubMed ID: 27538036
    [No Abstract]   [Full Text] [Related]  

  • 15. Most drugs paid for by £1.27bn Cancer Drugs Fund had no "meaningful benefit".
    Cohen D
    BMJ; 2017 Apr; 357():j2097. PubMed ID: 28455308
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer drug prices and the free-market forces.
    Kantarjian H; Zwelling L
    Cancer; 2013 Nov; 119(22):3903-5. PubMed ID: 24037953
    [No Abstract]   [Full Text] [Related]  

  • 17. India spurns cancer patents.
    Hayden EC
    Nature; 2013 Aug; 500(7462):266. PubMed ID: 23955214
    [No Abstract]   [Full Text] [Related]  

  • 18. In Cancer Care, Can We Afford To Hope?
    Hafner Z
    Manag Care; 2018 May; 27(5):31. PubMed ID: 29763406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Makers of anticancer drugs are "profiteering," say 100 specialists from around the world.
    Laurance J
    BMJ; 2013 Apr; 346():f2810. PubMed ID: 23633224
    [No Abstract]   [Full Text] [Related]  

  • 20. Genentech caps cost of cancer drug for some patients.
    Pollack A
    N Y Times Web; 2006 Oct; ():C2. PubMed ID: 17061339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.